期刊文献+

炎症与糖尿病肾病发生发展的关系 被引量:10

原文传递
导出
摘要 糖尿病肾病(DN)发病机制中除了糖脂代谢紊乱、血液动力学异常,炎症可能在DN进展中起着关键作用。炎症能引起DN,并在DN进展的整个过程中起了重要作用。目前已有学者在动物模型中应用抗炎治疗,延缓了DN的进展。
出处 《国际泌尿系统杂志》 2006年第5期714-717,共4页 International Journal of Urology and Nephrology
  • 相关文献

参考文献25

  • 1Navarro JF,Mora C,Maca M,et al.Inflammationtory parameters are independentlyassociated with urinary albumin in type 2 diabetes mellitus.Am J Kidney Dis,2003,42:53-61.
  • 2Anders HJ,Vielhauer V,Schlondorff D.Chemokines and chemokine receptors are involved in the resolution or progression of renal disease.Kidney Int,2003,63:401 -415.
  • 3Mensah-Brown EPK,Obineche EN,Galadari S,et al.Streptozotocin-induced diabetic nephropathy in rats:The role of inflammatory cytokines.CYTOKINE,2005,31 (3):180-190.
  • 4Lee SH,Lee TW,Ihm CG,et al.Genetics of diabetic nephropathy in type 2 DM:candidate gene analysis for the pathogenic role of inflammation.Nephrology,2005,10:S32-S36.
  • 5Navarro JF,Mora C.Role of inflammation in diabetic complications.Nephrology dialysis transplantation,2005,20(12):2601 -2604.
  • 6Sfakianaki M,Xydakis D,Papadogiannakia A,et al.Low-grade inflammation is correlated to diabetic nephropathy in type 2 diabetes mellitus.Diabetologia,2005,48:A375-A376.
  • 7李静,李荣山.巨噬细胞在大鼠糖尿病肾病发病机制中的作用[J].中国中西医结合肾病杂志,2005,6(2):79-82. 被引量:10
  • 8Chow F,Ozols E,Nikolic Paterson DJ,et al.Macrophages in mouse type 2 diabetic nephropathy correlation with diabetic state and progression renal injury.Kidney Int,2004,65:116-128.
  • 9Sassy -Prigent C,Heudes D,Mandet C,et al.Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats.Diabetes,2000,49:466-475.
  • 10余堂宏,贾汝汉,陈健,熊燕,丁国华.霉酚酸酯对2型糖尿病大鼠肾脏单核细胞趋化蛋白-1表达的影响[J].中国中西医结合肾病杂志,2005,6(4):192-194. 被引量:8

二级参考文献41

  • 1高苹,贾汝汉,宋恩峰,褚瑰丽,丁国华.氟伐他汀、缬沙坦及两药合用对糖尿病大鼠肾小管间质病变的保护作用[J].中华肾脏病杂志,2004,20(3):218-219. 被引量:12
  • 2Aoyama I, Shimokata K, Niwa T. An oral adsorbent downregulates renal expression of genes that promote interstitial inflammation and fibrosis in diabetic rats. Nephron,2002, 92: 635-651.
  • 3Usui H, Shikata K, Matsuda M, et al.HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats. Nephrol Dial Transplant,2003, 18: 265-272.
  • 4Zoja C, Corna D, Rottoli D, et al. Effect of combining ACE inhibitor and statin in severe experimental nephropathy. Kidney Int, 2002, 61: 1635-1645.
  • 5Henke C, Marineili W,Jessurun J,et al. Macrophage production of basic fibroblast growth factor in the tibroproliferative disorder of alveolar fibrosis after lung injury. Am J Pathol, 1993, 143:1189-1199.
  • 6Nikolic Paterson DJ, Atkins RC. The role of macrophages in glomerulonephritis. Nephrol Dial Transplant. 2001, 16(Supp15):3-7.
  • 7Gueler F, Rong S, Park JK. Postischemic acute renal failure is reduced by short-term statin treatment in a rat model. J Am Soc Nephrol. 2002,13:2288-2298.
  • 8Park JK, Muller DN, Mervaala EM. Cerivastatin prevents angiotensin Ⅱ-induced renal injury independent of blood pressure-and cholesterol lowering effects. Kidney Int, 2000 . 58 : 1420-1430.
  • 9Usui H, Shikata K, Matsuda M. HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiolropic effects in rats. Nephrol Dial Transplant. 2003,18:265-272.
  • 10Guijarro C, Egido J. Transcription factor kappa B (NF-kappa B) and renal disease. Kidney Int. 2001 .59:415-424.

共引文献32

同被引文献91

引证文献10

二级引证文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部